Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bertani

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Kidney International|June 1, 1987
Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritisT Bertani, M Livio, D Macconi, et al.
Experimental Nephrology|December 5, 1997
Selective dietary restriction of protein and calorie intakes prevents spontaneous proteinuria in male MWF ratsD Macconi, W Laurens, S Paris, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1991
Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune miceM Morigi, D Macconi, E Riccardi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1991
Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)G Banfi, T Bertani, V Boeri, et al.
The New England Journal of Medicine|July 8, 1993
Prognosis of untreated patients with idiopathic membranous nephropathyA Schieppati, L Mosconi, A Perna, et al.
Journal of the American Society of Nephrology : JASN|April 15, 1999
Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal diseaseM Abbate, C Zoja, D Rottoli, et al.
Experimental Nephrology|July 1, 1996
Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injuryC Zoja, D Corna, I Bruzzi, et al.
Kidney International|August 1, 1993
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progressionA Benigni, C Zoja, D Corna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 1989
Pattern of double glomerulopathies: a clinicopathologic study of superimposed glomerulonephritis on diabetic glomerulosclerosisG Monga, G Mazzucco, G B di Belgiojoso, et al.
Nephron|January 1, 1990
Pattern of double glomerulopathies. A clinicopathologic study in nine nondiabetic patientsG Monga, G Mazzucco, G Barbiano di Belgiojoso, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Kidney International|June 1, 1987
Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritisT Bertani, M Livio, D Macconi, et al.
Experimental Nephrology|December 5, 1997
Selective dietary restriction of protein and calorie intakes prevents spontaneous proteinuria in male MWF ratsD Macconi, W Laurens, S Paris, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1991
Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune miceM Morigi, D Macconi, E Riccardi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1991
Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL)G Banfi, T Bertani, V Boeri, et al.
The New England Journal of Medicine|July 8, 1993
Prognosis of untreated patients with idiopathic membranous nephropathyA Schieppati, L Mosconi, A Perna, et al.
Journal of the American Society of Nephrology : JASN|April 15, 1999
Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal diseaseM Abbate, C Zoja, D Rottoli, et al.
Experimental Nephrology|July 1, 1996
Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injuryC Zoja, D Corna, I Bruzzi, et al.
Kidney International|August 1, 1993
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progressionA Benigni, C Zoja, D Corna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 1989
Pattern of double glomerulopathies: a clinicopathologic study of superimposed glomerulonephritis on diabetic glomerulosclerosisG Monga, G Mazzucco, G B di Belgiojoso, et al.
Nephron|January 1, 1990
Pattern of double glomerulopathies. A clinicopathologic study in nine nondiabetic patientsG Monga, G Mazzucco, G Barbiano di Belgiojoso, et al.
Pageof 10